Wang et al. reported a comprehensive meta-analysis that examined the CYP2C19 polymorphisms and the relationship with several cancers, including HCC, and found that PM status of CYP2C19 most likely contributes to cancer susceptibility. The gene discussed is CYP2C19; the disease is cancer.